First Quarter Highlights Revenue grows 26% year-over-year to $788.1 millionAnnual Recurring Revenue ("ARR") grows 26% year-over-year to $3,204 millionDeferred revenue grows 32% year-over-year to ...

Full-year 2025 guidance: non-GAAP operating margin -- Expected between 23.5% and 24.5%, reflecting increases in sales and ...

Zscaler will host a conference call for analysts and investors to discuss its first quarter of fiscal 2026 and outlook for its second quarter of fiscal 2026 and full year fiscal 2026 today at 1:30 p.m ...

Company well positioned to leverage strengthening market fundamentals Q3 2025 HighlightsRevenues of $27.5 million, versus $28.4 million in 2024Adjusted ...

Our philosophy often runs counter to prevailing market sentiment, especially in times of excessive concentration and narrow ...

A total of 1,948 hotels, or 219,359 hotel rooms, in operation as of September 30, 2025.Net revenues for the third quarter of 2025 increased by 38.4% year-over-year to RMB2,628 million (US$369 million) ...

Nutanix, Inc. (NASDAQ: NTNX), a leader in hybrid multicloud computing, today announced financial results for its first quarter ended October 31, 2025.

Security selection in industrials and a notable overweight to the software industry within information technology were the ...

During 2025, Silver X steadily reinforced its operational foundation, accessing higher-value mineral zones without increasing ...

We are thrilled to complete the acquisition of New Way and officially welcome its more than 750 employees to the Federal Signal family,” said Jennifer L. Sherman, President and Chief Executive Officer ...

Strategic Focus on QYOU USA and Chatterbox Technologies Drives Positive Financial Results Live Shareholder Call To Take Place ...

Detailed price information for Sangamo Therapeutics (SGMO-Q) from The Globe and Mail including charting and trades.